Figure 1
Treatment regimen. a; Patients were treated with GEM (1000 mg/m2) for 3 weeks (on days 1, 8, and 15) followed by 1 week of rest, while MUC1-DCs and MUC1-CTLs were administrated on day 18 every 4 weeks. b; MUC1-CTLs were induced by co-culture with YPK-1, a human pancreatic cancer cell line, and then with IL-2. DCs were generated by culture with GM-CSF and IL-4 and then exposed to TNF-α. Mature DCs were transfected with MUC1-mRNA by electroporation (MUC1-DCs).